Boxer Capital, LLC Buys Solid Biosciences Inc, Sarepta Therapeutics Inc, Madrigal Pharmaceuticals Inc, Sells AveXis Inc, Loxo Oncology Inc, G1 Therapeutics Inc

• New Purchases: SRPT, MDGL, KNSA, MEIP,
• Added Positions: SLDB, ESPR, MRTX, WVE, VKTX, DBVT,
• Reduced Positions: MGNX, PTCT, RIGL, CBAY, GTXI,
• Sold Out: AVXS, LOXO, GTHX, BPMC, IONS, AQXP, LJPC, DERM, BLCM,

For the details of Boxer Capital, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Boxer+Capital%2C+LLC

1. Solid Biosciences Inc (SLDB) - 2,780,000 shares, 11.22% of the total portfolio. Shares added by 270.67%
2. BeiGene Ltd (BGNE) - 630,000 shares, 10.97% of the total portfolio.
3. Mirati Therapeutics Inc (MRTX) - 1,565,560 shares, 8.74% of the total portfolio. Shares added by 14.07%
4. PTC Therapeutics Inc (PTCT) - 1,900,000 shares, 7.26% of the total portfolio. Shares reduced by 26.92%
5. Odonate Therapeutics Inc (ODT) - 2,826,938 shares, 7.07% of the total portfolio.

Boxer Capital, LLC initiated holding in Sarepta Therapeutics Inc. The purchase prices were between $71.74 and $153.69, with an estimated average price of $94.31. The stock is now traded at around $125.72. The impact to a portfolio due to this purchase was 5.61%. The holding were 375,000 shares as of 2018-06-30.

Boxer Capital, LLC initiated holding in Madrigal Pharmaceuticals Inc. The purchase prices were between $101.55 and $313.9, with an estimated average price of $174.17. The stock is now traded at around $233.78. The impact to a portfolio due to this purchase was 3.01%. The holding were 95,000 shares as of 2018-06-30.

Boxer Capital, LLC initiated holding in Kiniksa Pharmaceuticals Ltd. The purchase prices were between $16.73 and $20.35, with an estimated average price of $18.13. The stock is now traded at around $16.09. The impact to a portfolio due to this purchase was 2.3%. The holding were 1,172,700 shares as of 2018-06-30.

Boxer Capital, LLC initiated holding in MEI Pharma Inc. The purchase prices were between $1.89 and $4.95, with an estimated average price of $3.06. The stock is now traded at around $3.67. The impact to a portfolio due to this purchase was 1.3%. The holding were 2,913,091 shares as of 2018-06-30.

Boxer Capital, LLC added to a holding in Solid Biosciences Inc by 270.67%. The purchase prices were between $7.33 and $43.15, with an estimated average price of $20.49. The stock is now traded at around $38.48. The impact to a portfolio due to this purchase was 8.19%. The holding were 2,780,000 shares as of 2018-06-30.

Boxer Capital, LLC added to a holding in Esperion Therapeutics Inc by 52.78%. The purchase prices were between $36.2 and $76.4, with an estimated average price of $50.72. The stock is now traded at around $45.96. The impact to a portfolio due to this purchase was 2.11%. The holding were 1,375,000 shares as of 2018-06-30.

Boxer Capital, LLC sold out a holding in AveXis Inc. The sale prices were between $115.91 and $217.83, with an estimated average price of $198.8.

Boxer Capital, LLC sold out a holding in Loxo Oncology Inc. The sale prices were between $109.63 and $186.69, with an estimated average price of $149.85.

Boxer Capital, LLC sold out a holding in G1 Therapeutics Inc. The sale prices were between $35.06 and $51.17, with an estimated average price of $42.84.

Boxer Capital, LLC sold out a holding in Blueprint Medicines Corp. The sale prices were between $60.96 and $101.18, with an estimated average price of $79.51.

Boxer Capital, LLC sold out a holding in Ionis Pharmaceuticals Inc. The sale prices were between $40.53 and $50.7, with an estimated average price of $44.27.

Boxer Capital, LLC sold out a holding in Aquinox Pharmaceuticals Inc. The sale prices were between $2.26 and $15.72, with an estimated average price of $13.01.